Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT02229734
Eligibility Criteria:
Inclusion Criteria:
* High risk prostate cancer
* Has had multidisciplinary consultation with radiation oncologist and urologist
* Age \>70 or refuses standard treatment
* No evidence of extra-prostatic disease on screening bone scan and CT scan (non-contrast CT used for CT simulation acceptable)
* Signed written and voluntary informed consent provided.
* Patients must be willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures
Exclusion Criteria:
* Patients not meeting the eligibility criteria
* Prior pelvic radiotherapy or brachytherapy
* Use of anti-coagulation (low molecular weight heparin or Coumadin)
* History of inflammatory bowel disease, Crohn's disease, diverticulitis or collagen vascular disease (other than rheumatoid arthritis)
* Previous treatment for malignancy (other than basal or squamous cell skin cancer) within 3 years of prostate cancer diagnosis
* patients on androgen deprivation therapy \> 2 months prior to study enrolment
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
70 Years
Study:
NCT02229734
Study Brief:
Protocol Section:
NCT02229734